Introduction
Staphylococcus saprophyticus, a member of the coagulase-negative staphylococci (CoNS), is a common cause of acute uncomplicated urinary tract infection (UTI) in young, sexually active female outpatients, accounting for up to 42% of UTIs in this population [1] . More severe complications have also been reported, including acute pyelonephritis, septicaemia, nephrolithiasis and endocarditis, as well as infections in males such as urethritis, prostatitis and nephrolithiasis [2] . Except for fosfomycin, S. saprophyticus is susceptible to many antimicrobial agents, including macrolidelincosamide-streptogramin (MLS) antibiotics [3] [4] [5] [6] . However, since MLS antibiotics are excreted primarily in bile, they are not used for the treatment of UTIs. As a consequence, resistance to these antibiotics has been poorly documented in S. saprophyticus in comparison with other CoNS. Although S. saprophyticus appears to be an exclusive uropathogen, its major reservoir is the gastrointestinal tract, with the most common site being the rectum [7] , and its mode of transmission may be through consumption of contaminated animal food products [8] . An study in the UK [9] as well as preliminary results from University Hospital of Caen (France) (unpublished data) showed a high prevalence of MLS resistance in S. saprophyticus, indicating that this species might be a potential reservoir of MLS resistance genes. However, molecular characterisation of resistance has not been yet investigated.
Although MLS antibiotics are chemically distinct, they are classified in the same group owing to their similar mechanism of action and spectrum of activity [10] . Macrolides are classified according to the number of atoms forming the lactone ring, i.e. 14-membered Page 5 of 28 A c c e p t e d M a n u s c r i p t (e.g. erythromycin), 15-membered (e.g. azithromycin) or 16-membered (e.g. spiramycin). Lincomycin and clindamycin belong to the lincosamides, and streptogramins correspond to a mixture of two compounds that act synergistically, i.e. streptogramins A (e.g. dalfopristin) and streptogramins B (e.g. quinupristin). MLS antibiotics act by inhibiting protein synthesis following binding to the 50S subunit (23S rRNA) of the bacterial ribosome [10] .
In staphylococci, MLS resistance is mediated by three major mechanisms, namely target site modification, active efflux and drug inactivation [10] . Ribosomal alteration is mediated by a methyltransferase, encoded by erm genes (erythromycin ribosome methylase), which methylates the A2058 residue in domain V of the 23S rRNA.
Although nearly 40 erm genes have been reported so far (http://faculty.washington.edu/marilynr/), erm(A), erm(B) and erm(C) genes are the most frequently detected in staphylococci. This methylation results in the so-called MLS B phenotype, which can be expressed either inducibly or constitutively. Inducible expression is characterised by unique resistance to 14-and 15-membered ring macrolides, which are inducers. Constitutive expression is characterised by resistance to all macrolides, lincosamides and streptogramins B. Mutations in 23S rRNA (A2058 and A2059) and in ribosomal proteins L4 and L22 (encoded by rplD and rplV genes, respectively) have been infrequently described [11] [12] [13] . Active efflux is mediated by the msr(A) gene that codes for a putative efflux pump and is responsible for the so-called M phenotype characterised by unique resistance to 14-and 15-membered ring macrolides. The L phenotype is related to acquisition of the lnu(A) gene (formerly known Page 6 of 28 A c c e p t e d M a n u s c r i p t as linA or linA') that encodes 3-lincomycin, 4-clindamycin O-nucleotidyltransferase, which only inactivates lincosamides.
Since molecular characterisation of MLS resistance has not been yet undertaken in S. saprophyticus, the aim of this study was to evaluate the prevalence of MLS resistance among a collection of S. saprophyticus clinical isolates recovered from a French hospital and to identify genes associated with this resistance as well as their genetic supports.
Materials and methods

Bacterial isolates
From 2005 to 2009, a total of 72 S. saprophyticus clinical isolates were recovered from urine specimens (pure culture ≥10 5 colony-forming units/mL) from the University Hospital of Caen (France). Isolates were identified to species level using a VITEK 2 ID-GPC card (bioMérieux, Marcy l'Etoile, France) in accordance with the manufacturer's instructions. Sequencing of the sodA gene was performed as described previously for 14 isolates because biochemical identification was equivocal [14] . To detect putative mutations responsible target for site modification, a portion of the rrl gene for domain V of the 23S rRNA gene as well as the entire sequence of the rplD, rplV and rplC genes (coding for L4, L22 and L3 ribosomal proteins, respectively) were amplified by PCR using the conditions described above and specific primers ( Table 1) .
Antimicrobial susceptibility testing
Polymerase chain reaction (PCR) amplification and sequencing
Purified PCR products were then directly sequenced with the same sets of primers in both directions by GATC Biotech (Konstanz, Germany).
Plasmid analysis and conjugation
Plasmid DNA of MLS-resistant strains was prepared using a modification of the Kieser technique [19] . Lysostaphin was substituted for lysozyme and was used at a final Conjugation experiments using the streptomycin-resistant S. aureus 80CR5 strain as recipient were performed in solid culture media [20] . Transconjugants were selected on brain-heart infusion agar plates containing streptomycin (20 mg/L) and erythromycin (2 mg/L).
Results
Antimicrobial susceptibility
All 72 S. saprophyticus clinical isolates studied were susceptible to cefoxitin, aminoglycosides, glycopeptides, ofloxacin, linezolid, fusidic acid, rifampicin and SXT. 
Characterisation of MLS resistance genes
The most prevalent resistance determinant was msr(A), which was detected alone in 24 strains (72.7%), followed by erm(C) and lnu(A) detected alone in 5 strains (15.2%) and 1 strain (3.0%), respectively ( Table 2) . Two strains (6.1%) were positive for both msr(A) and lnu(A) genes, whereas a single strain (strain no. 15) was negative for all screened genes. No erm(A) and erm(B) genes were detected. All isolates harbouring the msr(A) gene alone exhibited an M phenotype with a moderate level of resistance to erythromycin (MIC = 4-128 mg/L) and susceptibility to other MLS antibiotics ( Table 2) . Since this phenotype did not correspond to any known resistance gene(s), the presence of chromosomal mutations in domestic genes was evaluated. No mutation was detected in rrl, rplD and rplV genes, whereas a unique mutation (A103G) leading to an isofunctional substitution (I35V) was found in the rplC gene. Therefore, the mechanism of MLS resistance in this isolate remains unknown. Fig. 1(A1) ,(A2)], whereas that of erm(C)-and lnu(A)-containing plasmids was much smaller, ca. 2.5 kb [ Fig. 1(B) ,(C)].
Genetic support of MLS resistance genes
Since erm(C)-and lnu(A)-containing plasmids were, in theory, too small to be self- 
Discussion
In this study, S. saprophyticus clinical isolates were susceptible to almost all antimicrobial agents. These findings are in agreement with previously reported data where the prevalence of acquired resistance is generally <5% [3] [4] [5] [6] 9, 21, 22] , confirming that S. saprophyticus is a multisusceptible species. Although all of the studied strains were susceptible to cefoxitin, meticillin resistance by acquisition of the mecA gene has been rarely reported [23, 24] . Surprisingly, the prevalence of MLS resistance, particularly to erythromycin, is much higher than previously reported. According to studies conducted in the early 1980s, the prevalence of resistance to erythromycin and clindamycin varied from 8% to 16% and 0% to 6%, respectively [3] [4] [5] [6] . Only a single study conducted in the UK in the late 1990s reported a higher prevalence (25.1%) of resistance to erythromycin, whilst the prevalence of resistance to clindamycin was only 1.5% [9] . A more recent study on antimicrobial susceptibility of S. saprophyticus clinical isolates recovered in Japan in 2003 showed that only 10 isolates (9.9%) were highly resistant to erythromycin (MIC ≥ 64 mg/L) [23] . The high incidence of MLS resistance in the collection of isolates studied here might be the reflection of a particular situation in our hospital or a global evolution towards increased resistance. Finally, no S. saprophyticus resistant to the combination Page 14 of 28 A c c e p t e d M a n u s c r i p t of streptogramins A and B was found in this study; this resistance has not been yet reported in this species.
No data are available regarding the distribution of MLS resistance genes in S.
saprophyticus. This study showed that the distribution of these genes is different from that generally reported for CoNS, mostly Staphylococcus epidermidis, S. haemolyticus and Staphylococcus hominis [17, [25] [26] [27] . In these species, the most prevalent gene is generally erm(C) with a prevalence ranging from 44% to 78%, followed by the erm(A) gene with a prevalence ranging from 5% to 32%. Efflux of macrolides due to msr(A) is a mechanism found in only a minority of CoNS, representing 11-24% of erythromycin resistance [17, [25] [26] [27] . In contrast, in this study MLS resistance in S. saprophyticus was mainly due to the presence of the msr(A) gene, as previously described in S.
haemolyticus [28] . The erm(B) gene was not detected in this study, however this is not surprising since this resistance gene has been seldom described in staphylococci previously. Little is known about the prevalence of the lnu(A) gene in CoNS. A study reporting a prevalence of 5% identified a frequent association with msr(A) or an erm gene [17] . Note that a single study contrasts with data from other studies, reporting a high occurrence of msr(A) (53%) and lnu(A) (30%) genes among a collection of 98
CoNS comprising mostly S. haemolyticus (n = 62) and S. epidermidis (n = 27) [29] .
The genetic support of MLS resistance in S. saprophyticus has been poorly studied.
The current findings are similar to those previously reported for S. aureus and CoNS. erm(C) genes are usually located on small, structurally related, multicopy plasmids Page 15 of 28 A c c e p t e d M a n u s c r i p t ranging in size between 2.3 kb and 2.5 kb, and more rarely on structurally diverse larger plasmids of 3.7-4 kb [30] . To date, only one erm(C)-carrying plasmid of 4 kb has been characterised from S. saprophyticus [31] . lnu(A) genes are also located on small, structurally different plasmids of 2.3-3.8 kb [32, 33] , whereas the msr(A) gene was located on larger plasmids of ca. 20-40 kb [30, 34] . Results of conjugation experiments suggest that these msr(A)-containing plasmids do not encode their own transfer function. However, they might be mobilised by other mobile elements, which remain to be evidenced. Finally, exchange of erm(C)-and lnu(A)-containing plasmids might be due to generalised transduction mediated by many bacteriophages known to be present in staphylococci [35] .
For S. saprophyticus strain no. 15, only a single point mutation has been identified in the rplC gene coding for the L3 ribosomal protein. Various mutations in this gene have been only associated with resistance to oxazolidinones [36, 37] and pleuromutilins [38] , but at different positions. However, strain no. 15 was entirely susceptible to linezolid (an oxazolidinone) and tiamulin (a pleuromutilin) (data not shown). The involvement of this mutation in putative MLS resistance should be confirmed by site-directed mutagenesis.
In addition, this strain harboured at least two plasmids (sizes ca. 60 kb and 80 kb) A c c e p t e d M a n u s c r i p t saprophyticus is mainly due to the presence of the plasmid-mediated msr(A) gene and that this species may be a reservoir of these resistance genes among staphylococci.
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